Understanding how immune privilege in the eye affects inflammation and retinal diseases
Immune Privilege, Müller cells, and Autophagy
This study is looking at how special cells in the eye help keep our vision healthy by fighting inflammation, which could lead to new ways to help people manage or prevent vision loss from eye diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10872176 on NIH RePORTER |
What this research studies
This research investigates the unique immune response of the eye, focusing on Müller cells, which are crucial for maintaining retinal health. The study aims to understand how these cells utilize a process called autophagy to suppress inflammation and protect vision. By examining specific models of eye inflammation in mice, the researchers will explore the relationship between immune privilege and retinal diseases, potentially leading to new therapeutic strategies. Patients may benefit from insights into how to better manage or prevent vision loss associated with inflammatory conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with retinal diseases or conditions that involve inflammation in the eye.
Not a fit: Patients with non-inflammatory eye conditions or those not affected by retinal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that protect vision by enhancing the eye's natural anti-inflammatory mechanisms.
How similar studies have performed: Previous research has shown promising results in understanding immune privilege in the eye, but this specific approach focusing on Müller cells and autophagy is relatively novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ferguson, Thomas Almon — Washington University
- Study coordinator: Ferguson, Thomas Almon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.